Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer

被引:4
作者
Bartoletti, Michele [1 ]
Pignata, Sandro [2 ]
Lorusso, Domenica [3 ,4 ]
Perrone, Francesco [5 ]
Zara, Diego [1 ,6 ]
Puglisi, Fabio [1 ,6 ]
机构
[1] Ist Ricovero Cura Carattere Sci IRCCS, Centro Riferimento Oncologico Aviano, Dept Med Oncol, Unit Med Oncol & Canc Prevent, Aviano, Italy
[2] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Urol & Gynecol, Naples, Italy
[3] Fdn Policlin Univ Gemelli IRCCS, Div Gynecol Oncol, Dept Women & Child Hlth, Rome, Italy
[4] Catholic Univ Sacred Heart Largo Agostino Gemelli, Dept Life Sci & Publ Hlth, Rome, Italy
[5] Ist Nazl Tumori IRCCS, Fdn G Pascale, Clin Trials Unit, Naples, Italy
[6] Univ Udine, Dept Med, Udine, Italy
关键词
BEVACIZUMAB;
D O I
10.1001/jamanetworkopen.2022.45077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 6 条
[1]   Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Banerjee, Susana ;
Moore, Kathleen N. ;
Colombo, Nicoletta ;
Scambia, Giovanni ;
Kim, Byoung-Gie ;
Oaknin, Ana ;
Friedlander, Michael ;
Lisyanskaya, Alla ;
Floquet, Anne ;
Leary, Alexandra ;
Sonke, Gabe S. ;
Gourley, Charlie ;
Oza, Amit ;
Gonzalez-Martin, Antonio ;
Aghajanian, Carol ;
Bradley, William H. ;
Holmes, Eileen ;
Lowe, Elizabeth S. ;
DiSilvestro, Paul .
LANCET ONCOLOGY, 2021, 22 (12) :1721-1731
[2]   Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer [J].
Gonzalez-Martin, A. ;
Pothuri, B. ;
Vergote, I. ;
DePont Christensen, R. ;
Graybill, W. ;
Mirza, M. R. ;
McCormick, C. ;
Lorusso, D. ;
Hoskins, P. ;
Freyer, G. ;
Baumann, K. ;
Jardon, K. ;
Redondo, A. ;
Moore, R. G. ;
Vulsteke, C. ;
O'Cearbhaill, R. E. ;
Lund, B. ;
Backes, F. ;
Barretina-Ginesta, P. ;
Haggerty, A. F. ;
Rubio-Perez, M. J. ;
Shahin, M. S. ;
Mangili, G. ;
Bradley, W. H. ;
Bruchim, I. ;
Sun, K. ;
Malinowska, I. A. ;
Li, Y. ;
Gupta, D. ;
Monk, B. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25) :2391-2402
[3]   A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45) [J].
Monk, Bradley J. ;
Parkinson, Christine ;
Lim, Myong Cheol ;
O'Malley, David M. ;
Oaknin, Ana ;
Wilson, Michelle K. ;
Coleman, Robert L. ;
Lorusso, Domenica ;
Bessette, Paul ;
Ghamande, Sharad ;
Christopoulou, Athina ;
Provencher, Diane ;
Prendergast, Emily ;
Demirkiran, Fuat ;
Mikheeva, Olga ;
Yeku, Oladapo ;
Chudecka-Glaz, Anita ;
Schenker, Michael ;
Littell, Ramey D. ;
Safra, Tamar ;
Chou, Hung-Hsueh ;
Morgan, Mark A. ;
Drochytek, Vit ;
Barlin, Joyce N. ;
Van Gorp, Toon ;
Ueland, Fred ;
Lindahl, Gabriel ;
Anderson, Charles ;
Collins, Dearbhaile C. ;
Moore, Kathleen ;
Marme, Frederik ;
Westin, Shannon N. ;
McNeish, Iain A. ;
Shih, Danny ;
Lin, Kevin K. ;
Goble, Sandra ;
Hume, Stephanie ;
Fujiwara, Keiichi ;
Kristeleit, Rebecca S. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (34) :3952-3964
[4]   Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis [J].
Paoletti, Xavier ;
Lewsley, Liz-Anne ;
Daniele, Gennaro ;
Cook, Adrian ;
Yanaihara, Nozomu ;
Tinker, Anna ;
Kristensen, Gunnar ;
Ottevanger, Petronella B. ;
Aravantinos, Gerasimos ;
Miller, Austin ;
Boere, Ingrid A. ;
Fruscio, Robert ;
Reyners, Anna K. L. ;
Pujade-Lauraine, Eric ;
Harkin, Andrea ;
Pignata, Sandro ;
Kagimura, Tatsuo ;
Welch, Stephen ;
Paul, James ;
Karamouza, Eleni ;
Glasspool, Rosalind M. .
JAMA NETWORK OPEN, 2020, 3 (01)
[5]   A Phase 3 Trial of Bevacizumab in Ovarian Cancer [J].
Perren, Timothy J. ;
Swart, Ann Marie ;
Pfisterer, Jacobus ;
Ledermann, Jonathan A. ;
Pujade-Lauraine, Eric ;
Kristensen, Gunnar ;
Carey, Mark S. ;
Beale, Philip ;
Cervantes, Andres ;
Kurzeder, Christian ;
du Bois, Andreas ;
Sehouli, Jalid ;
Kimmig, Rainer ;
Staehle, Anne ;
Collinson, Fiona ;
Essapen, Sharadah ;
Gourley, Charlie ;
Lortholary, Alain ;
Selle, Frederic ;
Mirza, Mansoor R. ;
Leminen, Arto ;
Plante, Marie ;
Stark, Dan ;
Qian, Wendi ;
Parmar, Mahesh K. B. ;
Oza, Amit M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26) :2484-2496
[6]   Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer [J].
Ray-Coquard, I. ;
Pautier, P. ;
Pignata, S. ;
Perol, D. ;
Gonzalez-Martin, A. ;
Berger, R. ;
Fujiwara, K. ;
Vergote, I. ;
Colombo, N. ;
Maenpaa, J. ;
Selle, F. ;
Sehouli, J. ;
Lorusso, D. ;
Alia, E. M. Guerra ;
Reinthaller, A. ;
Nagao, S. ;
Lefeuvre-Plesse, C. ;
Canzler, U. ;
Scambia, G. ;
Lortholary, A. ;
Marme, F. ;
Combe, P. ;
de Gregorio, N. ;
Rodrigues, M. ;
Buderath, P. ;
Dubot, C. ;
Burges, A. ;
You, B. ;
Pujade-Lauraine, E. ;
Harter, P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25) :2416-2428